12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Tuesday's intraday session, several healthcare stocks experienced significant movements. RayzeBio (RYZB) saw a 100.8% increase to $61.4 with a market cap of $3.6 billion. IMAC Hldgs (BACK) rose 74.02% to $4.21, and Gracell Biotechnologies (GRCL) went up by 59.93% to $9.9. Conversely, Milestone Pharmaceuticals (MIST) dropped 32.3% to $1.95, ENDRA Life Sciences (NDRA) fell 22.01% to $1.95, and Jin Medical International (ZJYL) declined by 18.51% to $111.67.
December 26, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Milestone Pharmaceuticals' shares fell by 32.3% to $1.95, with a market cap of $65.2 million.
The sharp decline in Milestone Pharmaceuticals' stock price suggests negative sentiment that could persist in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
ENDRA Life Sciences' stock dropped by 22.01% to $1.95, with a market cap of $16.4 million.
ENDRA Life Sciences' significant stock price decrease could indicate a bearish outlook, potentially leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Jin Medical International's stock decreased by 18.51% to $111.67, with a market cap of $865.4 million.
The decline in Jin Medical International's stock price reflects negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
IMAC Hldgs' stock increased by 74.02% to $4.21, with a market cap of $4.7 million.
The substantial rise in IMAC Hldgs' stock price suggests a positive short-term outlook, though the small market cap may indicate higher volatility.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Gracell Biotechnologies' shares rose by 59.93% to $9.9, with a market cap of $949.6 million.
A significant increase in Gracell Biotechnologies' stock price could attract more investor attention, potentially maintaining the upward momentum in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
RayzeBio's stock surged by 100.8% to $61.4, with a market cap of $3.6 billion.
A surge of 100.8% in stock price indicates strong investor interest and positive sentiment, likely to continue in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100